Research Article

1. Abstract 1.1. Background: Despite promising short-term results, revision from Sleeve Gastrectomy (SG) to Roux-en-Y gastric bypass (RYGBP) can be required due to either inadequate weight loss or weight regain (IWL/WR), or de novo complications, such as gastroesophageal reflux disease (GERD) or gastric stenosis. 1.2. Objectives: To report surgical outcomes in converting SG to RYGBP …

Which Laparoscopic Sleeve Gastrectomies Convert into Roux En Y Gastric Bypass? A Prospective Monocentric Study About 50 Patients Read More »

1. Abstract 1.1. Background: We have assessed an approach, enabling an endoscopist together with surgical assistance to perform endoscopic sutures based on minimally-invasive principles. 1.2. Aim: Assessment of a new suturing-system in the gastrointestinal tract. http://dx.doi.org/10.47829/JJGH.2021.6202

1. Abstract 1.1. Introduction: Hepatitis B virus (HBV) infection, a pan global health problem, has already effected one-third of the world popula- tion. India harbours around 40 million HBV carriers, thus account- ing for 10–15% share of total pool of HBV carriers of the world. Every year over 100,000 Indians die due to illnesses related …

Epidemiological Profile and Clinical Spectrum of Hepatitis B-Ten Years Experience at Tertiary Care Centre of Northeren India Read More »

1. Abstract 1.1. Introduction: Viral hepatitis is an important health problem in India and is caused by Hepatitis A, B, C, D, E and G virus which can lead to acute or chronic infection. 1.2. Aims & Objectives: To determine the genotype of chron- ic hepatitis C patients attending Department of Gastroenterology, PGIMS Rohtak. 1.3. …

HCV Genotype 2 is Rare in India – Ten Years’ Experience at Tertiary Care Center of Northeren India Read More »

1. Abstract 1.1. Background: Previous studies reported that Non-Alcoholic Fatty Liver Disease (NAFLD) is associated with gallbladder stone disease (GSD). The study aimed to detect the key factors influencing the formation of new-onset GSD among the NAFLD patients. DOI:http://dx.doi.org/10.47829/JJGH.2021.51301

1. Abstract 1.1. Objective: Spontaneous Bacterial Peritonitis (SBP) is a big complication of severe complication “ascites” in patients with cirrhosis. There are three clinical forms of SBP (1982) – latent, classical and fulminant. Classic symptoms of peritonitis in SBP are usually absent. Diagnosis of SBP is established if polymorphonuclears (PMNs) in ascitic fluid are >250/mm3 …

Clinical and Laboratory Forms of Conteporary Manifestation of Spontaneous Bacterial Peritonitis Read More »

1. Abstract 1.1. Background: Spontaneous Bacterial Peritonitis (SBP) is a big complication of liver cirrhosis with ascites. Ascitic Fluid Total Protein (AFTP) is still used to determine the risk of SBP in cirrhotic patients with ascites. There are single reports of the role of serum-ascites albumin gradient (SAAG) in the diagnosis of SBP. 1.2. Aim: …

Change of the Ascitic Fluid Total Protein in Natural Progression of Liver Cirrhosis and Serum Ascites Albumin Gradient in Patients with Spontaneous Bacterial Peritonitis Versus Patients with Cirrhosis and Sterile Ascites Read More »

1. Abstract 1.1. Introduction: This study aimed to investigate whether pancreatic secondary signs on contrast-enhanced dynamic CT are really specific for patients with pancreatic adenocarcinomas. 1.2. Methods: A retrospective review of dynamic CT findings was performed for 93 patients with suspected pancreatic adenocarcinomas and with any secondary CT signs. Among these 93 patients with secondary …

Secondary Signs Related to Pancreatic Adenocarcinomas on CT: Are They Really Specific Findings for Malignancies? Read More »

DOI:http://dx.doi.org/10.47829/JJGH.2021.51003

1. Abstract 1.1. Aims: The poor prognoses of hepatitis B virus (HBV) infection are correlated with hepatitis B e antigen (HBeAg). Current antiviral therapy does not directly interfere with HBeAg synthesis. HBeAg formation depends on proprotein convertase furin. To block HBeAg synthesis on purpose, galactosylated arginine-rich macromolecular furin inhibitors were developed and evaluated. DOI:http://dx.doi.org/10.47829/JJGH.2021.51002